B. Mwaikambo

发表

Genetic Ablation of CD36 Induces Age-Related Corneal Neovascularization

P. Hardy, S. Chemtob, F. Sennlaub, 2008, Cornea.

Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy

Y. Courtois, F. Behar-Cohen, S. Chemtob, 2003, Circulation.

RNA Isolation and Reverse Transcription – Polymerase Chain Reaction ( PCR )

Y. Courtois, F. Behar-Cohen, S. Chemtob, 2003 .

Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways.

Chun Yang, P. Hardy, S. Chemtob, 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration.

A. Di Polo, Chun Yang, P. Hardy, 2009, Investigative ophthalmology & visual science.

New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.

P. Hardy, S. Chemtob, F. Sennlaub, 2005, Prostaglandins, leukotrienes, and essential fatty acids.

Inflammatory lipid mediators in ischemic retinopathy.

P. Hardy, S. Chemtob, F. Sennlaub, 2005, Pharmacological reports : PR.

Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.

P. Hardy, S. Chemtob, F. Sennlaub, 2006, Investigative ophthalmology & visual science.

Hypoxia Up-regulates CD36 Expression and Function via Hypoxia-inducible Factor-1- and Phosphatidylinositol 3-Kinase-dependent Mechanisms*

Chun Yang, P. Hardy, S. Chemtob, 2009, The Journal of Biological Chemistry.

Emerging roles for the CD36 scavenger receptor as a potential therapeutic target for corneal neovascularization.

P. Hardy, S. Chemtob, H. Ong, 2008, Endocrine, metabolic & immune disorders drug targets.

Age–dependent Spontaneous Induction of Corneal Neovascularization in CD36 Knock–out Mice

P. Hardy, S. Chemtob, F. Sennlaub, 2004 .